Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure.
about
Labetalol infusion in acute myocardial infarction with systemic hypertension.Manipulating afterload for the treatment of acute heart failure. A historical summary.Treatment of hypertension in acute stage of myocardial infarction. Haemodynamic effects of labetalol.Salbutamol in cardiogenic shock complicating acute myocardial infarction.Circulatory effects of controlled arterial hypotension with trimetaphan (Arfonad). Experimental study in patients with left ventricular failurePhentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction. Haemodynamic study.Effects of phentolamine on coronary blood flow in patients with recent myocardial infarctionVasodilator therapy in acute myocardial infarction. Use of sublingual isosorbide dinitrate.Comparison of haemodynamic effects of phentolamine, sodium nitroprusside, and glyceryl trinitrate in acute myocardial infarctionRole of sublingual nitroglycerin in patients with acute myocardial infarction.Comparison of nitroglycerin-, nitroprusside-, and phentolamine-induced changes in coronary collateral function in dogs.Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure.Vasodilators in acute circulatory failure.Vasodilator treatment for acute and chronic heart failure.A comparison of the electrophysiological actions of phentolamine with those of some other antiarrhythmic drugs on tissues isolated from the rat heart.Electrophysiologic properties of nitroprusside in man.Prognostic significance of acute systolic hypertension after myocardial infarction.Drug action, reaction, and interaction. II. Iatrogenic cardiopathies.
P2860
Q34517830-25D79DF9-871B-48B2-8C81-B042D97D7C82Q35056422-DC3D3F02-FD3B-4D13-8E88-62319CB68C9FQ36744393-F4F34A5C-4FDC-4B41-B386-8556AA54E3DBQ36772896-8DC09979-88EA-4DAC-96D4-ECA6BA7D02E4Q36788238-9E31265D-73BE-4E65-8017-90673C508BD5Q36789318-CA306E2B-AC8D-4F2F-8165-0580A6C332AAQ36789340-984114CF-023E-4584-9A82-8A72FFB823FDQ36803971-78400083-3701-4878-ACD4-80BD5BB5EAB0Q36804693-95375638-8DD7-4AEA-8C89-EF9065FD4803Q36819504-B6DC4C66-0FEA-4F04-8095-918472DCA5BAQ37045808-9E9B0E1E-E24E-4899-A3EC-4DAB91C7D35DQ39693445-EE246DCD-5A38-490E-9242-0F1000E78660Q40206682-A1AB78F8-9F96-4892-9910-B8D35996D572Q41329843-19A0AF56-A2FC-4D2C-B63D-872290F5527BQ42185532-AEE53E80-DDD5-4072-983C-025E0E7958BBQ43493776-32CE393C-35FF-4459-A2F5-B94396301BF7Q49810832-F04CE0DD-8598-4799-B2A8-327D008E9D98Q52715527-1DC61323-7C32-4741-92FF-B4E4EB53039E
P2860
Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
Use of phentolamine in acute m ...... and left ventricular failure.
@en
Use of phentolamine in acute m ...... and left ventricular failure.
@nl
type
label
Use of phentolamine in acute m ...... and left ventricular failure.
@en
Use of phentolamine in acute m ...... and left ventricular failure.
@nl
prefLabel
Use of phentolamine in acute m ...... and left ventricular failure.
@en
Use of phentolamine in acute m ...... and left ventricular failure.
@nl
P2093
P356
P1433
P1476
Use of phentolamine in acute m ...... and left ventricular failure.
@en
P2093
P304
P356
10.1161/01.CIR.47.4.729
P407
P577
1973-04-01T00:00:00Z